Same industry

REGN against four drug peers, a year at 100

80100120140160Feb ’26MayAugNov ’26LLY+27.1%JNJ+32.7%ABBV+21.1%MRK+36.8%REGN+21.8%

REGN +21.8%. Merck +36.8%, Johnson & Johnson +32.7%, Eli Lilly +27.1%, AbbVie +21.1%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in REGN’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

REGN: stories, the record and filings →